Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innoleo is a specialty chemical company that focuses on the production and distribution of high-quality castor oil and its derivatives. The company serves as a key supplier to the pharmaceutical and personal care industries, providing oleochemicals that function as excipients, emollients, and chemical intermediates. Their product portfolio includes sebacic acid, ricinoleic acid, and various esters used in the formulation of topical treatments and oral medications. Innoleo emphasizes sustainable sourcing and green chemistry, positioning its products as renewable alternatives to traditional petroleum-based chemicals. The company is headquartered in Florida and maintains a global distribution network to support its diverse client base in the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innoleo.